Language Select
Varian Logo

Recent News

February 20, 2018
Varian (NYSE: VAR) today announced three of its cancer care solutions have been named Category Leaders in the 2018 Best in KLAS: Software and Services Report by KLAS, an independent research firm... Read more
February 06, 2018
Varian (NYSE: VAR) today announced the Halcyon™ cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply in India. This registration allows... Read more
February 05, 2018
Varian (NYSE: VAR) today announced it has acquired privately-held Mobius Medical Systems®, a leader in radiation oncology Quality Assurance (QA) software. This acquisition expands Varian's... Read more

Recent Blog Posts

Feb 16, 2018 | Centerline
Researchers have reported that cervical cancer patients who are treated with combined external beam radiotherapy (EBRT) and brachytherapy appear to have a significantly better overall survival... Read more
Jan 03, 2018 | Spot ON Blog
Proton-Man symbolizes the determination and technology that doctors employ when they utilize proton therapy to fight cancer. Proton-Man's mission is to spread the word about proton therapy and... Read more
Nov 29, 2017 | Spot ON Blog
The potential benefits of proton therapy have yet to be realized. That motivated a group of us to undertake a comprehensive look at the physics and technology powering intensity-modulated proton... Read more

Get News Releases by Email
Subscribe Now

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
VP, Investor Relations
650.424.5163
[email protected]